Biotechnology News

August 1, 2012

WEST ORANGE, N.J.--(BUSINESS WIRE)--ZRG reports increased hiring in Q2. Global Life Sciences hiring demand up 11%. Europe driving hiring trends up significantly in medical device and diagnostics, sales talent and manufacturing.

August 1, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (NYSE: LH) today announced it is aware of the recent reports regarding possible plans by private equity firms to seek to effect a leveraged buyout of the Company. The...

August 1, 2012

TEL AVIV, Israel--(BUSINESS WIRE)--Tikcro Technologies Ltd. (OTC PK: TIKRF) today reported results for the second quarter ended June 30, 2012. Net loss for the second quarter was $124,000, or $0.01 per diluted share. Results for the second...

August 1, 2012

SEATTLE--(BUSINESS WIRE)--Sage Bionetworks has been ranked #2 in The Scientist’s tenth international survey of best places to work in academia. The Scientist noted that in this year’s survey, researchers around the world said they valued the...

August 1, 2012

CAMBRIDGE, England & BOSTON, Mass.--(BUSINESS WIRE)--FDA Chooses Linguamatics Text Mining Platform

August 1, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--PharmaVOICE magazine has named Comprehend Systems, Inc. CEO Rick Morrison to its annual list of the 100 most inspiring people in the life sciences industry

August 1, 2012

BOSTON--(BUSINESS WIRE)--Acetylon initiates 2 Phase 1b clinical trials for the treatment of relapsed and relapsed/refractory multiple myeloma.

August 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme announced its participation in the Wedbush 2012 Life Sciences: Management Access Conference on Wednesday, August 15 at 3:40pm.

August 1, 2012

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended June 30, 2012. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share,...

August 1, 2012

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced...

August 1, 2012

CHARLOTTE, N.C.--(BUSINESS WIRE)--Hospitals, healthcare providers to benefit from new Premier agreements for personal care kits and components

August 1, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen to Release Second Quarter 2012 Results

August 1, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--ABL will provide R&D and cGMP manufacturing services to improve the government's response to emerging disease threats.

August 1, 2012

ALAMEDA, Calif. & JERUSALEM--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Cell Cure Neurosciences Ltd. (Cell Cure) today announced that Cell Cure has been awarded a grant for 2012 of 5.04 million Shekels (approximately $1...

August 1, 2012

WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced that Lee Babiss, Ph.D., chief scientific officer and executive vice president of global laboratory services, has been named to the 2012 P

August 1, 2012

NEW YORK--(BUSINESS WIRE)--Medidata Solutions announced vice president of implementation services Marco van Doeveren was named by PharmaVOICE magazine as one of the 100 most inspiring people in the life sciences industry.

August 1, 2012

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (NYSE: LH) today announced the completion of its acquisition of MEDTOX Scientific, Inc. (NASDAQ: MTOX), effective July 31, 2012. At a special meeting held on July 31,...

August 1, 2012

WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida reports Alimera to resubmit application to FDA for ILUVIEN in DME using data from completed trials

August 1, 2012

SALT LAKE CITY--(BUSINESS WIRE)--Sorenson Genomics, a leading provider of DNA and molecular diagnostic testing, has received accreditation from the College of American Pathologists (CAP).

August 1, 2012

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (NASDAQ: PURE), today announced that with 86% of shares outstanding voted at its annual meeting of stockholders convened July 31, 2012, Gregory Barnhill, Dennis Brovarone, John Carbone, MD, Michael...

August 1, 2012

BURLINGTON, Mass.--(BUSINESS WIRE)--Competitive Landscape Seminar Series: Biologics and Biosimilars will be held on October 4, 2012. This high-value, one-day seminar has been developed specifically for biopharmaceutical companies.

August 1, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Gemmus Pharma adds three new Board members. Experienced biotech industry veterans from the Life Science Angels, Bayer Schering and Innovation works will add start-up company and clinical expertise.

August 1, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that its Board of Directors declared a third quarter dividend of $0.23 per common share. This dividend amount is equal to the...

August 1, 2012

SHEFFIELD, England--(BUSINESS WIRE)--Simcyp enhances flagship Simulator in line with industry priorities

August 1, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix expands QuantiGene ViewRNA license with Siemens for in vitro diagnostics using in situ hybridization.

August 1, 2012

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Announces Expiration of the
Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, Inc.

August 1, 2012

PLEASANTON, Calif.--(BUSINESS WIRE)--Analyst Study Concludes Veeva Systems is the Leading CRM System Provider to the U.S. Pharmaceutical Industry

August 1, 2012

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced it will host a...

August 1, 2012

NEW YORK--(BUSINESS WIRE)--New York Genome Center (NYGC) today announced the launch of its Innovation Center, which will provide access to new sequencing technologies and foster collaboration among NYGC’s Institutional Founding Members (IFMs) and...

August 1, 2012

LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, will present at the upcoming Wedbush PacGrow LifeSciences...

August 1, 2012

LONDON--(BUSINESS WIRE)--New market report “China Genetic Engineering Drug Industry Report, 2011-2012” worked out by ResearchInChina has been recently published by Market Publishers Ltd.

August 1, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent completes its acquisition of Asterand Human Tissue Business. The purchase is a step in Stemgent's strategy to build a research tools business focused on human cells for R&D and drug discovery

August 1, 2012

IRVINE, Calif. & LIEGE, Belgium--(BUSINESS WIRE)--MDxHealth, a developer of epigenetic tests for cancer, has received CAP accreditation for its Irvine lab. The first product offered is the recently launched ConfirmMDx™ for Prostate Cancer...

August 1, 2012

BURLINGTON, Ontario--(BUSINESS WIRE)--Clinical findings show the innovative Canadian delivra™ system penetrates into the skin and muscle 687% deeper than the ingredients in leading topical creams.

July 31, 2012

ALACHUA, Fla.--(BUSINESS WIRE)--AxoGen, Inc. (OTCBB: AXGN), a leading regenerative medicine company focused on the development and commercialization of products and technologies for peripheral nerve reconstruction and regeneration, announced...

July 31, 2012

VALENCIA, Calif.--(BUSINESS WIRE)--MannKind Corporation (Nasdaq: MNKD) will release its 2012 second quarter financial results on Tuesday, August 7, 2012 and its management will host a conference call to discuss the second quarter financial...

July 31, 2012

LAKE ZURICH, Ill. & WORCESTER, Mass.--(BUSINESS WIRE)--Experts call for new steps to improve platelet safety, including the use of the Verax Platelet PGD® test administered at hospitals prior to transfusion.

July 31, 2012

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals (NYSE: NAVB) Completes License for Parkinson's Disease Imaging Agent with Alseres: Adds second promising neuroimaging candidate to growing pipeline

July 31, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its second quarter 2012 financial results on August 7, 2012, after close of market.

July 31, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. (NASDAQ:HPTX) announced today the completion of its initial public offering of 5,000,000 shares of common stock. In addition, the underwriters of its initial public...

July 31, 2012

ROCHESTER, N.Y.--(BUSINESS WIRE)--Transcat, Inc. (NASDAQ: TRNS) (“Transcat” or the “Company”), a leading distributor of professional grade handheld test, measurement and control instruments and accredited provider of calibration, repair,...

July 31, 2012

GAINESVILLE, Fla.--(BUSINESS WIRE)--Q2 Earnings Release

July 31, 2012

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NVDL.PK) reports unaudited financial results for the six months ended June 30, 2012.

July 31, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB: INSV) today announced that patient enrollment has begun in the first Phase 3 clinical trial of BromSite™ (ISV-303) for the reduction of pain and inflammation after cataract...

July 31, 2012

ALAMEDA, Calif.--(BUSINESS WIRE)--InSite Vision Incorporated (OTCBB:INSV) today reported financial results for the quarter ended June 30, 2012. Total revenues for the second quarter of 2012 were $1.8 million, a decrease of $1.3 million from the...

July 31, 2012

BOULDER, Colo.--(BUSINESS WIRE)--ARRY-797 met its primary endpoint in a randomized, placebo-controlled and active-controlled (oxycodone ER) Phase 2 clinical trial in 157 osteoarthritis patients suffering from moderate to severe pain.

July 31, 2012

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc., (NASDAQ:AFFX) today reported its operating results for the second quarter of 2012. Total revenue for the quarter was $66.4 million, including approximately $1.4 million in revenue from...

July 31, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will report financial results for the second quarter ending June 30, 2012 on Monday, August 6, 2012,...